期刊文献+

持续恒速输注异丙酚在大鼠无肝期前后血药浓度变化的研究

Changes of propofol blood concentrations in rats during anhepatic phase by continuous constant-speed infusion of propofol
暂未订购
导出
摘要 目的探讨异丙酚持续恒速输注在大鼠无肝期前后血药浓度变化规律、肝外代谢、肺脏对异丙酚肝外代谢的作用。方法通过大鼠左颈深静脉持续恒速输注异丙酚,于分离肝门时、肝门阻断即刻、肝门阻断15、30、60 m in等时间点,同时从右侧颈深动、静脉分别采血(100μl),采用高效液相色谱荧光法(HPLC)检测异丙酚血药浓度。结果颈深静脉或颈深动脉异丙酚血药浓度各时相点间比较,肝门阻断15、30、60 m in时的血药浓度比阻断前和阻断即刻明显升高(P<0.01),但3组间没有显著性差异(P>0.05);颈深静脉与颈深动脉异丙酚血药浓度比较,任何时刻均无显著性差异(P>0.05)。结论肝脏是异丙酚主要代谢器官,异丙酚存在肝外代谢,肺脏不是异丙酚肝外代谢的主要器官。 Objective To observe the changes of propofol blood concentrations in rats during anhepatic phase by continuous constant-speed infusion of propofol and to investigate the extrahepatic metabolism of propofol and the effects of lungs on the extrahepatic metabolism of propofol. Methods When the continuous constant-speed transfusion of propofol was carrying out through the left deep cervical vein, the blood samples of 100 txl were withdrawn simultaneously from the right deep cervical artery and vein at the flowing time points: 5 min before the dissociation of hepatic portal, immediate devascularization of the hepatic portal, 15 min, 30 min and 60 min after devascularization of the hepatic portal. The propofol blood concentrations were analyzed by HPLC. Results At 15 min, 30 rain and 60 min after the devascularization of the hepatic portal, the propofol blood concentrations in the right deep cervical artery and vein were significantly higher than that at 5 min before the dissociation of hepatic portal and immediate devascularization of the hepatic portal ( P 〈 0.01 ). The propofol blood concentrations were of no significant difference at 15, 30 and 60 min after the devascularization of the hepatic portal. The blood propofol concentrations in the deep cervical artery and vein were of no significant differences at any time points. Conclusion The liver is the main organ for propofol metabolism. Extrahepatic metabolism of propofol exists but the lung is not the main organ for propofol extrahepatic metabolism.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2005年第17期1766-1768,共3页 Journal of Third Military Medical University
基金 第三军医大学青年科研基金资助项目(2004)~~
关键词 异丙酚 无肝期 肝外代谢 propofol anhepatic phase extrahepatic metabolism
  • 相关文献

参考文献10

  • 1Veroli P, O' Kelly B, Bertrand F, et al. Extrahepatic metabolism of propofol in man during the anhepatic phase of orthotopic liver transplantation[J]. Br J Anaesth, 1992, 68(2): 183 - 186.
  • 2顾健腾,陶国才,鲁开智,吴洲.大鼠肾脏异丙酚代谢相关ugt1a6基因在无肝期表达变化的研究[J].第三军医大学学报,2005,27(16):1697-1699. 被引量:9
  • 3Knibbe C A, Koster V A, Deneer V H, et al. Determination of propofol in low-volume samples by high-performance liquid chromatography with fluorescence detection [ J ]. J Chromatogr B Biomed Sci Appl,1998, 706(2): 305-310.
  • 4Kothare P A, Zimmerman C L. Intestinal metabolism: the role of enzyme localization in phenol metabolite kinetics [ J ]. Drug Metab Dispos, 2002, 30(5): 586-594.
  • 5Raoof A A, Obbergh L J, Ville G J, et al. Exerahepatic glucuronidation of propofol in man: possible contribution of gut wall and kidney[J]. Eur J Clin Pharmacol, 1996, 50(1 -2): 91 -96.
  • 6He Y L, Ueyama H, Tashiro C, et al. Pulmonary disposition of propofol in surgical patients[J]. Anesthesiology, 2000, 93(4): 986 -991.
  • 7古妙宁,盖成林,林春水,欧阳铭文,徐建设,周俊岭.恒速静脉输注异丙酚时脑摄取的研究[J].中华麻醉学杂志,2001,21(3):133-135. 被引量:16
  • 8Zhang S H, Li Q, Yao S L, et al. Subcellular expression of UGT1 A6 and CYP1 A1 responsible for propofol metabolism in human brain [ J ].Acta Pharmacol Sin, 2001, 22( 11 ): 1013 - 1017.
  • 9Le Guellec C, Lacarelle B, Villard P H, et al. Glucuronidation of propofol in microsomal fractions from various tissues and species including humans: effect of different drugs[J]. Anesth Analg, 1995, 81(4): 855 -861.
  • 10Kuipers J A, Boer F, Olieman W, et al. First - pass lung uptake and pulmonary clearance of propofol: assessment with a recirculatory indocyanine green pharmacokinetic model [ J ]. Anesthesiology, 1999, 91(6): 1780 -1787.

二级参考文献10

  • 1Ethell B T, Ekins S, Wang J, et al. Quantitative structure activity relationships for the glucuronidation of simple phenols by expressed human ugt1α6 and UGT1A9[J]. Drug Metab Dispos, 2002, 30(6):734 - 738.
  • 2Raoof A A, van Obbergh L J, de Ville de Goyet J, et al. Extrahepatic glucuronidation of propofol in man: possible contribution of gut wall and kidney[J]. Eur J Clin Pharmacol, 1996, 50(1 -2): 91 -96.
  • 3Gueraud F, Daveloose D, Vezin H, et al. In vivo modification of the UDP-glucuronosyltransferase functional state in rat liver following hypophysectomy and partial or complete hormonal restoration [ J ]. J Biochem (Tokyo), 2003, 134(5): 641 -653.
  • 4Hiroshi Y, Yohko K, Yasuko S, et al. Effects on extrahepatic UDPglucuronosyltransferases in hypophysectomized rat[ J]. J Biochem (Tokyo), 2002, 132(2): 265 -270.
  • 5Shelby M K, Cherrington N J, Vansell N R, et al. Tissue mRNA expression of the rat UDP-glucuronosyltransferase gene family [ J ]. Drug Metab Dispos, 2003, 31 (3): 326 -333.
  • 6Veroli P, O' Kelly B, Bertrand F, et al. Extrahepatic metabolism of propofol in man during the anhepatic phase of orthotopic liver transplantation[J]. Br J Anaesth, 1992, 68(2): 183 - 186.
  • 7Le Guellec C, Lacarelle B, Villard P H, et al. Glucuronidation of propofol in microsomal fractions from various tissues and species including humans: effect of different drugs[J]. Anesth Analg, 1995, 81(4):855-861.
  • 8Richard N. Upton,Laurence E. Mather,William B. Runciman,Craig Nancarrow,Ronda J. Carapetis. The use of mass balance principles to describe regional drug distribution and elimination[J] 1988,Journal of Pharmacokinetics and Biopharmaceutics(1):13~29
  • 9朱益贫,杨立群,俞卫锋.小儿肝移植无肝期丙泊酚的药代动力学特点[J].第二军医大学学报,2001,22(9):875-877. 被引量:8
  • 10李新.人体内的葡醛酸结合反应及其影响因素[J].中国临床药理学杂志,2002,18(5):387-395. 被引量:7

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部